Anticancer effects of Ganoderma lucidum: A review of scientific evidence

Nutrition and Cancer

Volumn 53, Issue 1, 2005, Pages 11-17

  Yuen, John W M ^a   Gohel, Mayur Danny I ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ACTIVITY; CANCER PATIENT; CANCER PREVENTION; CANCER THERAPY; CELLULAR IMMUNITY; CHINA; DIET SUPPLEMENTATION; GANODERMA LUCIDUM; HEALTH PROMOTION; HUMAN; LUNG CANCER; MITOGENESIS; QUALITY OF LIFE; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUGS, CHINESE HERBAL; EVIDENCE-BASED MEDICINE; HUMANS; REISHI;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 30344482855     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5301_2     Document Type: Review

References (57)

1. Drašar P and Moravcova J: Recent advances in analysis of Chinese medical plants and traditional medicines. J Chromatogr B 812, 1-2, 2004.
2. Chen AW and Miles PG: Biomedical research and the application of mushroom nutriceuticals from Ganoderma lucidum. In Mushroom Biology and Mushroom Products, Chang ST, Buswell JA, and Chiu SW (eds). Hong Kong: Chinese University Press, 1996, pp 161-175.
3. Chang ST and Buswell JA: Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)-a mushrooming medicinal mushroom. Int J Med Mushr 1, 139-146, 1999.
4. Wachtel-Galor S, Tomlinson B, and Benzie IFF: Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 91, 263-269, 2004.
5. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, et al.: Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 11, 151-166, 1995.
6. Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19, 65-96, 1999.
7. Schraub S: Unproven methods in cancer: a worldview problem. Support Care Cancer 8, 10-15, 2000.
8. Gao YH, Chan E, and Zhou SF: Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Rev Int 20, 123-161, 2004.
9. Gao YH and Zhou SF: Chemopreventive and tumoricidal properties of Ling Zhi mushroom Ganoderma lucidum (W.Curt.: Fr.)Lloyd (Aphyllophoromycetideae). II. Mechanism considerations. Int J Med Mushr 6, 219-230, 2004.
10. Tomasi S, Lohézic-Le Dévéhat F, Sauleau P, Bézivin C, and Boustie J: Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie 59, 290-293, 2004.
11. Cao QZ and Lin ZB: Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25, 833-838, 2004.
12. Lin ZB and Zhang HN: Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25, 1387-1395, 2004.
13. Kim HS, Kacew S, and Lee BM: In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller; Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 20, 1637-1640, 1999.
14. Adam JK, Odhav B, and Bhoola KD: Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 11, 151-166, 2003.
15. Sliva D: Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2, 358-364, 2003.
16. Gao YH, Tang WB, Gao H, Lam J, and Zhou SF: Chemopreventive and tumoricidal properties of Lingzhi mushroom Ganoderma lucidum (W. Curt.:Fr.) Lloyd (Aphyllophorophoromycetideae). I. Preclinical and clinical studies (review). Int J Med Mushr 6, 95-106, 2004.
17. Zhu M, Chang Q, Wong LK, Chong FS, and Li RC: Triterpene antioxidants from Ganoderma lucidum. Phytother Res 13, 529-531, 1999.
18. Min BS, Gao JJ, Nakamura N, and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem Pharm Bull 48, 1026-1033, 2000.
19. Gao JJ, Min BS, Ahn E, Nakamura N, Lee HK, et al.: New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull 50, 837-840, 2002.
20. Hsiao WLW, Li YQ, Lee TL, Li N, You MM, et al.: Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis 25, 1177-1183, 2004.
21. Miyazaki T and Nishijima M: Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29, 3611-3616, 1981.
22. Liu X, Yuan JP, Chung CK, and Chen XJ: Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett 182, 155-161, 2002.
23. Lin JL and Shiao MS: Triterpenes from Ganoderma lucidum. Phytochemistry 27, 2269-2271, 1988.
24. Upton R: Reishi mushroom Ganoderma lucidum: standards of analysis, quality control, and therapeutics. Am Herbal Pharmacopoeia 10, 1-25, 2000.
25. Lin CN and Tome WP: Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod 54, 998-1002, 1991.
26. Jiang J, Slivova V, Harvey K, Valachovicova T, and Sliva D: Ganoderma lucidum suppresses growth of breast cancer through the inhibition of Akt/NF-κB signaling. Nutr Cancer 49, 209-216, 2004.
27. Jiang J, Slivova V, Valachovicova T, Harvey K, and Sliva D: Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24, 1093-1099, 2004.
28. Hu H, Ahn NS, Yang X, Lee YS, and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102, 250-253, 2002.
29. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, et al.: Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216, 9-20, 2004.
30. Zhu HS, Yang XL, Wang LB, Zhao DX, and Chen L: Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16, 201-206, 2000.
31. Chung WT, Lee SH, Kim JD, Park YS, Hwang B, et al.: Effect of mycelial culture broth of Ganoderma lucidum on the growth characteristics of human cell lines. J Biosci Bioeng 92, 550-555, 2001.
32. Lin SB, Li CH, Lee SS, and Kan LS: Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72, 2381-2390, 2003.
33. Hong KJ, Dumn DM, Shen CL, and Pence BC: Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res 18, 768-770, 2004.
34. Miura T, Yuan L, Sun B, Fujii H, Yoshida M, et al.: Isoflavone aglycon produced by culture of soybean extracts with Basidiomycetes and its anti-angiogenic activity. Biosci Biotechnol Biochem 66, 2626-2631, 2002.
35. Song YS, Kim SH, Sa JH, Jin C, Lim CJ, et al.: Anti-angiogenesis and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 90, 17-20, 2004.
36. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP, et al.: Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298, 603-612, 2002.
37. Sliva D, Sedlak M, Silvova V, Valachovicova T, Lloyd FP, et al.: Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9, 491-497, 2003.
38. Slivova V, Valachovicova T, Jiang J, and Sliva D: Ganoderma lucidum inhibits invasiveness of breast cancer cells. J Cancer Integr Med 2, 25-29, 2004.
39. Kimura Y, Taniguchi M, and Baba K: Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22, 3309-3318, 2002.
40. Lee SS, Wei YH, Chen CF, Wang SY, and Chen KY: Antitumor effects of Ganoderma lucidum. J Chin Med 6, 1-12, 1995.
41. Yun TK, Kim SH, and Lee YS: Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer 15, 839-845, 1995.
42. Yun TK: Update from Asia. Asian studies on cancer chemoprevention. Ann NY Acad Sci 889, 157-192, 1999.
43. Lu H, Kyo E, Uesaka T, Katoh O, and Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep 10, 375-379, 2003.
44. Lee SS, Chen FD, Chang SC, Wei YH, Liu I, et al.: In vivo antitumor effect of crude extracts from the mycelium of Ganoderma lucidum. Zhonghua Minguo Aizheng Yixuehui Huikan 5, 22-28, 1984.
45. Gao YH, Gao H, Chan E, Tang WB, Xu AL, et al.: Antitumor activity and underlying mechanisms of Ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol Invest 34, 171-198, 2005.
46. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, et al.: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70, 699-705, 1997.
47. Wang YY, Khoo KH, Chen ST, Lin CC, Wong CH, et al.: Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem 10, 1057-1062, 2002.
48. Bao XF, Wang XS, Dong Q, Fang JN, and Li XY: Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59, 175-181, 2002.
49. Bao XF, Zhen Y, Ruan L, and Fang JN: Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem Pharm Bull 50, 623-629, 2002.
50. Ooi VEC and Liu F: Immunomodulation an anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7, 715-729, 2000.
51. Mao T, Van de Water J, Keen CL, Stern JS, Hackman R, et al.: Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int J Immunother 15, 13-22, 1999.
52. Ohno N, Miura NN, Sugawara N, Tokunaka K, and Yadomae T: Immunomodulation by hot water and ethanol extracts of Ganoderma lucidum. Pharm Pharmacol Lett 8, 174-177, 1998.
53. Won SJ, Lee SS, Ke YH, and Lin MT: Enhancement of splenic NK cytotoxic activity by extracts of Ganoderma lucidum mycelium in mice. J Biomed Lab Sci 2, 201-213, 1999.
54. Lieu CW, Lee SS, and Wang SY: The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12, 1211-1216, 1992.
55. Gao YH, Zhou SF, Jiang WQ, Huang M, and Dai XH: Effects of Ganopoly® (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32, 201-215, 2003.
56. Gao YH, Dai XH, Chen GL, Ye JX, and Zhou SF: A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W.Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly®) in patients with advanced lung cancer. Int J Med Mushr 5, 369-381, 2003.
57. Gao YH, Zhou SF, Chen GL, Dai XH, and Ye JX: A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. Extract (Ganopoly) in patients with advanced cancer. Int J Med Mushr 4, 207-214, 2002.